Malic Acid

Also known as: L-malic acid, DL-malic acid, Hydroxysuccinic acid

A food acid and cosmetic pH ingredient with formulation-dependent irritation and separate short-term oral dry-mouth research.

A painted-paper collage of a whole green apple and a small peel curl.
Editorial illustration

Malic acid has food and cosmetic formulation uses. CIR's final 2022 amendment found malic acid and sodium malate safe under the cosmetic practices and concentrations described, with attention to irritation. Separate 1% oral-spray studies suggest short-term dry-mouth benefit. Those oral findings leave skin-treatment efficacy unresolved.2, 1, 4

  • The final 2022 CIR assessment explicitly supersedes the older 2001 conclusion for malic acid and sodium malate.1
  • A 28-person graft-versus-host disease trial tested a 1% malic-acid oral spray for two weeks.3
  • U.S. food conditions exclude baby food and specify category-dependent uses and maximum levels.2

What is Malic Acid?

Malic acid occurs in foods as the L form, while manufactured material can be a DL mixture. Cosmetic formulations may use the acid or its sodium salt for different stated functions. Route, final pH and complete formulation determine which evidence applies.2, 1

Where it comes from

Natural sources

  • L-malic acid occurs naturally in foods.

How it's made

The food regulation describes commercial DL-malic acid made from fumaric or maleic acid.

What it does in products

  • Cosmetic pH adjustment and fragrance functions
  • Food flavoring and pH control
  • Acid component investigated in oral dry-mouth sprays

Benefits

A short-term oral dry-mouth signal

limited evidence

The clinical evidence concerns a spray applied inside the mouth.4, 3

A meta-analysis of five articles involving 244 patients reported improved dry-mouth scores and salivary flow after two weeks with 1% sprays. Its authors called for better-quality studies. A separate 28-person placebo-controlled trial involved chronic graft-versus-host disease, limiting transfer to other causes of dry mouth.

Evidence scope and limitations

Specified cosmetic and food uses, the final 2022 cosmetic safety amendment and short-term 1% oral-spray research.

  • The oral trial and meta-analysis were checked through their original indexed abstracts because full texts were unavailable at this check. The meta-analysis appeared online in January 2022 and in the April 2023 issue, which supplies its publication year here.
  • CIR evaluates safety under reported cosmetic practices. Clinical effectiveness for skin conditions needs direct efficacy evidence.
  • The oral studies' two-week duration leaves long-term symptom control and dental outcomes unresolved.

Evidence last checked: 2026-11-15

Side effects & safety

Skin or eye irritation in unsuitable formulations (varies)CIR identifies irritation and final formulation pH as important considerations. Its discussion advises reducing irritation and minimizing eye exposure in relevant products. Acid percentage alone leaves the finished product's irritation potential incompletely described.
1, 3, 4

Amounts studied & product use

These figures describe research or common product use, not a personal dose or treatment recommendation.

Across cosmetic and oral-spray studies

CIR reported malic acid use up to 2.1% in certain leave-on cosmetics, within the practices it assessed. The dry-mouth studies instead tested a 1% spray applied in the oral cavity over two weeks. These are formulation and research contexts. The cited evidence leaves a personal home-peel recipe or general oral supplementation amount unestablished.

1, 3, 4

Regulatory status

  • U.S. food uses are specified in 21 CFR 184.1069. FDA classifies cosmetic and drug products by intended use and claims. A finished product making treatment claims enters a different regulatory context from a cosmetic pH-adjusting ingredient.
  • INCI name on cosmetic labels: Malic Acid / Sodium Malate.
  • The final 2022 amended assessment found both ingredients safe in the present cosmetic practices and concentrations described, superseding the 2001 conclusion.
2, 5, 1

Keep the final assessment and the administration route in view

CIR's 2022 amendment supplies the updated cosmetic safety conclusion. Using an older pH-adjuster-only summary would omit that revision. The assessment still concerns the reported formulation practices and safety endpoints.

The spray research addresses dry-mouth symptoms and salivary flow in the oral cavity. Its short duration leaves durability and long-term oral safety incompletely characterized. Evidence of a salivary response leaves independent acne, pigmentation and exfoliation claims to be tested in appropriate skin studies.

1, 3, 4

Frequently asked questions

Does the 1% spray research establish a skincare concentration?

The 1% studies used an oral spray and measured dry-mouth outcomes. Cosmetic safety is covered by a separate assessment of finished topical formulations, where pH and irritation matter. Each route retains its own evidence scope.3, 4, 1

The bottom line

Read malic acid through the current final assessment, complete formulation and actual administration route.

References

  1. Burnett CL, Bergfeld WF, Belsito DV, et al.. Amended Safety Assessment of Malic Acid and Sodium Malate as Used in Cosmetics. International Journal of Toxicology (2022) · safety assessment · DOI 10.1177/10915818221117535; 41(3 Suppl):69S–76S; final published assessment checked, explicitly superseding the 2001 conclusion
  2. 21 CFR 184.1069 — Malic acid. U.S. Food and Drug Administration / eCFR · government guidance · Current food regulation checked November 15, 2026 for L/DL identity, functions, baby-food exclusion and category-specific levels
  3. Bardellini E, Amadori F, Conti G, Veneri F, Majorana A. Effectiveness of a spray containing 1% malic acid in patients with xerostomia induced by graft-versus-host disease. Medicina Oral, Patología Oral y Cirugía Bucal (2019) · randomized trial · PMID 30818311; DOI 10.4317/medoral.22699; March 1, 2019, 24(2):e190–e194; indexed original abstract checked, full text unavailable at this check
  4. Liu G, Qiu X, Tan X, Miao R, Tian W, Jing W. Efficacy of a 1% malic acid spray for xerostomia treatment: A systematic review and meta-analysis. Oral Diseases (2023) · meta analysis · PMID 34954846; DOI 10.1111/odi.14116; PROSPERO CRD42021241322; April 2023, 29(3):862–872, online January 17, 2022; original abstract checked, full text unavailable
  5. Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?). U.S. Food and Drug Administration · government guidance · Current undated agency resource checked November 15, 2026 for intended-use classification and cosmetic versus drug requirements

Revision history

  1. Initial AI-assisted source compilation with claim-level citations, formulation distinctions and explicit evidence limitations; not independent medical review.